Cost-Effectiveness of Empagliflozin In Patients With Type 2 Diabetes Mellitus At High Cardiovascular Risk In Poland

Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.453
https://www.valueinhealthjournal.com/article/S1098-3015(17)30787-8/fulltext
Section Title : Disease-Specific Studies
Section Order : 428
First Page : A478
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30787-8&doi=10.1016/j.jval.2017.08.453
HEOR Topics :
Tags :
Regions :